CL Stock Today: February 13 – Staples Rotation After AI Jitters

CL stock is back on the radar as money moves into defensive names after AI-related volatility hit cyclical areas. Colgate-Palmolive (CL) traded near $96.17 today, with a day range of $95.41 to $98.13 and a 52-week high of $100.18. The market cap sits around $77.5 billion. With investors seeking steady cash flows, we examine recent performance, Colgate-Palmolive earnings quality, valuation, and short-term technicals to decide how CL stock fits a cautious, income-leaning portfolio.

Why CL Is Gaining as Investors Seek Safety

The consumer staples rally picked up as AI disruption stocks pressured office real estate and logistics. A sharp selloff in those areas has investors favoring predictable demand and margins. This shift supported CL stock as buyers sought stability and dividends. CNBC reported office real estate weakness linked to AI’s impact on tenants and demand, reinforcing the defensive bid for staples source.

CL stock has risen 8.9% since its Q4 print, according to Yahoo Finance, underscoring appetite for earnings visibility in a risk-off tape source. Shares change hands around $96.17, up 23.8% year to date and within sight of the $100.18 52-week high. Volume near 6.7 million is in line with averages, signaling healthy interest without signs of blow-off buying.

Earnings Quality and Cash Flow Support

Colgate-Palmolive earnings quality looks solid. TTM EPS is $2.63 and the P/E is about 36.6, reflecting a stability premium. Operating margin runs near 21.3%. FY 2024 growth was broad based, with EPS up about 27% and operating cash flow per share at $5.22. Free cash flow per share of $4.52 highlights strong conversion, a key pillar for CL stock during periods of macro stress.

CL stock offers a 2.15% TTM dividend yield on $2.08 per share, with an 85.5% payout ratio. Free cash flow comfortably covers the dividend, though the ratio bears monitoring. Debt to equity is elevated near 148%, but interest coverage of 16.2 times and a current ratio around 1.0 help offset risk. Reliable cash generation supports continued buybacks and steady dividend growth.

Valuation and Analyst Stance

At roughly 36.6 times TTM earnings and 3.84 times sales, CL stock trades at a premium that investors often pay for steady brands, global reach, and recurring demand. Strong free cash flow and high returns on invested capital near 30% help justify that pricing. The market is rewarding resilience as rates stay restrictive and growth leadership chops and changes.

Twelve Buy ratings and a 4.00 consensus point to constructive sentiment. The next scheduled report is April 24, 2026. We will watch pricing power, mix upgrades, and Hill’s momentum. For CL stock, clean inventory, disciplined SG&A, and steady pet nutrition should matter most. Any signs of trade-down pressure or currency headwinds would be key watch items.

Technical Picture for Short-Term Traders

Momentum favors bulls. RSI sits near 61.7, MACD is positive, and Money Flow Index is above 70. ADX near 15.7 signals a weak trend, so breakouts may lack follow-through. CCI around 123 suggests overbought conditions. For CL stock, that mix points to a constructive bias, but we prefer buying pullbacks over chasing strength when oscillators flash caution.

Price is close to resistance near the $100.18 52-week high. Today’s range between $95.41 and $98.13 sets immediate pivots. With ATR around $1.45, traders can size stops near 1 to 1.5 times ATR. Longer-term, rising 50-day and 200-day averages near $82.92 and $84.38 keep the trend positive, supporting buy-the-dip strategies in CL stock.

Final Thoughts

CL stock benefits from a safety bid as investors rotate into staples while AI-linked sectors struggle. The company’s steady operating margin, strong cash conversion, and a 2.15% dividend yield support total return potential. Valuation is not cheap, but quality often commands a premium when growth leadership is uncertain. Near term, momentum is positive yet not extended enough to force immediate action. For a balanced plan, consider dollar-cost averaging on pullbacks toward recent intraday levels, and reassess after the April 24 earnings. Watch pricing power, pet nutrition, and currency impacts. Position size with ATR-informed stops and keep expectations grounded in income plus modest growth.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.